Skip to main content

Maria Buti Ferret

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Maria Buti Ferret

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Optimización del algoritmo diagnóstico para el cribado de infección por virus de la hepatitis D en la población atendida en el área de cobertura de la sanidad pública de la ciudad de Barcelona.

IP: Ariadna Rando Segura
Collaborators: Maria Buti Ferret, David Tabernero Caellas, Maria Francesca Cortese
Funding agency: Gilead Sciences, S.L.U.
Funding: 27000
Reference: GILEAD/HEPATITIS/2022/RANDO
Duration: 22/02/2023 - 30/09/2025

D-Mongolia: screening and linkage-to-care for Hepatitis D in Mongolian nationals living in Spain - Modalitat hepatitis

IP: Maria Buti Ferret
Collaborators: Maria del Mar Riveiro Barciela
Funding agency: Gilead Sciences, S.L.U.
Funding: 48763
Reference: GLD21_00139
Duration: 30/06/2022 - 30/04/2025

Impact of HLA haplotypes and HDV viremia in developing of clinical events and quality of life of patients with chronic hepatitis delta.

IP: Maria Buti Ferret
Collaborators: Maria Jose Herrero Mata, Ana Barreira Diaz, Maria del Mar Riveiro Barciela, Jordi Llaneras Artigues, Adriana Palom Agusti
Funding agency: Instituto de Salud Carlos III
Funding: 117370
Reference: PI20/01692
Duration: 01/01/2021 - 30/06/2025

No hepatitis B infections without linkage to treatment: research in a large health area of Barcelona

IP: Maria Buti Ferret
Collaborators: -
Funding agency: Gilead Sciences, Inc.
Funding: 125537.02
Reference: GLD20_IN-ES-320-6107_HBV2020
Duration: 13/09/2021 - 12/09/2023

Related news

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Julia Moltó Cuesta

Julia Moltó Cuesta

Read more
Yann Bertolani

Yann Bertolani

Read more
Inés Carolina Balón  Llerena

Inés Carolina Balón Llerena

Administration and Management
Molecular Medical Imaging
Read more
Elida Teresa Mercado Santis

Elida Teresa Mercado Santis

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.